Your session is about to expire
← Back to Search
Methylphenidate Hydrochloride ER + Behavioral Classroom + Academic Accommodations for ADHD
This trial is testing if different treatments, alone or combined, help kids with ADHD in school. It will look at things like how well they pay attention and how productive they are.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have been diagnosed with ADHD.You must have an IQ score of 70 or higher.You have been diagnosed with ADHD.You must have an IQ score of at least 70.You have a severe form of Autism Spectrum Disorder.
- Group 1: Placebo
- Group 2: Methylphenidate ER (.3 mg/kg dose)
- Group 3: General Classroom
- Group 4: Positive Behavior Support Classroom
- Group 5: Academic accommodations
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the academic modifications provided to individuals secure?
"The safety of Academic Accommodations has been established in previous clinical trials, so it receives a rating of 3."
To what extent can individuals partake in this clinical trial?
"This clinical trial is searching for 288 individuals with Attention Deficit Hyperactivity Disorder (ADHD), aged 5 to 12. To be considered eligible, prospective participants must meet the conditions outlined above."
How many participants are engaged in this experiment?
"Affirmative. The clinicaltrials.gov database indicates that this trial, which was initially posted on June 13th 2022, is actively enrolling patients. Over the course of two sites, 288 participants are required for completion of the study."
Is the age limit for participation in this research project above 30 years old?
"For this particular study, the eligible age range of participants is from 5 to 12 years old."
Are new participants being accepted at this time for the trial?
"Recent updates on clinicaltrials.gov indicate that this research effort, which was initially listed on June 13th 2022, is still looking for patients to partake in the study. The most recent edit occured on July 20th of the same year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Share this study with friends